Annual ROE
1531.23%
-6801.82%-81.62%
September 30, 2024
Summary
- As of February 6, 2025, SONN annual return on equity is 1531.23%, with the most recent change of -6801.82% (-81.62%) on September 30, 2024.
- During the last 3 years, SONN annual ROE has risen by +1728.89% (+874.68%).
- SONN annual ROE is now -81.62% below its all-time high of 8333.05%, reached on September 30, 2023.
Performance
SONN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-383.41%
+14.92%+3.75%
September 30, 2024
Summary
- As of February 6, 2025, SONN quarterly return on equity is -383.41%, with the most recent change of +14.92% (+3.75%) on September 30, 2024.
- Over the past year, SONN quarterly ROE has increased by +14.92% (+3.75%).
- SONN quarterly ROE is now -100.84% below its all-time high of 45.57 thousand%, reached on September 30, 2020.
Performance
SONN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SONN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -81.6% | +3.8% |
| 3 y3 years | +874.7% | +3.8% |
| 5 y5 years | +794.5% | +3.8% |
SONN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.6% | +608.0% | -41.1% | +89.9% |
| 5 y | 5-year | -81.6% | +290.6% | -100.8% | +91.0% |
| alltime | all time | -81.6% | +290.6% | -100.8% | +91.0% |
Sonnet BioTherapeutics Holdings ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | 1531.23%(-81.6%) | -383.41%(-3.7%) |
| Jun 2024 | - | -398.33%(+4.2%) |
| Mar 2024 | - | -382.18%(-59.8%) |
| Dec 2023 | - | -951.71%(-74.9%) |
| Sep 2023 | 8333.05%(-2864.6%) | -3788.99%(+16.6%) |
| Jun 2023 | - | -3250.20%(+110.5%) |
| Mar 2023 | - | -1543.70%(+108.3%) |
| Dec 2022 | - | -740.93%(+126.4%) |
| Sep 2022 | -301.42% | -327.26%(+10.4%) |
| Jun 2022 | - | -296.44%(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -271.65%(-15.1%) |
| Dec 2021 | - | -319.91%(-32.9%) |
| Sep 2021 | -197.66%(-75.4%) | -477.09%(-83.9%) |
| Jun 2021 | - | -2968.82%(-30.2%) |
| Mar 2021 | - | -4254.69%(-203.1%) |
| Dec 2020 | - | 4126.09%(-90.9%) |
| Sep 2020 | -803.51%(-569.4%) | 45.57 K%(+5154.7%) |
| Jun 2020 | - | 867.24%(+1497.4%) |
| Mar 2020 | - | 54.29% |
| Sep 2019 | 171.19% | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual return on equity?
- What is the all time high annual ROE for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual ROE year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly return on equity?
- What is the all time high quarterly ROE for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly ROE year-on-year change?
What is Sonnet BioTherapeutics Holdings annual return on equity?
The current annual ROE of SONN is 1531.23%
What is the all time high annual ROE for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual return on equity is 8333.05%
What is Sonnet BioTherapeutics Holdings annual ROE year-on-year change?
Over the past year, SONN annual return on equity has changed by -6801.82% (-81.62%)
What is Sonnet BioTherapeutics Holdings quarterly return on equity?
The current quarterly ROE of SONN is -383.41%
What is the all time high quarterly ROE for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly return on equity is 45.57 K%
What is Sonnet BioTherapeutics Holdings quarterly ROE year-on-year change?
Over the past year, SONN quarterly return on equity has changed by +14.92% (+3.75%)